Prognostic Value of the Expression of Tumor Suppressor Genes p53, p21, p16 and pRb, and Ki-67 Labelling in High Grade Astrocytomas Treated with Radiotherapy
- 1 January 2000
- journal article
- Published by Springer Nature in Journal of Neuro-Oncology
- Vol. 46 (1) , 71-80
- https://doi.org/10.1023/a:1006473320474
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Multivariate analysis of prognostic factors in 106 patients with malignant gliomaEuropean Journal Of Cancer, 1996
- Overexpression of the EGF Receptor and p53 Mutations are Mutually Exclusive in the Evolution of Primary and Secondary GlioblastomasBrain Pathology, 1996
- Molecular genetics and molecular biology advances in brain tumorsCurrent Opinion in Oncology, 1996
- The p53 gene and its role in human brain tumorsGlia, 1995
- Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samplesThe Journal of Pathology, 1994
- Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumorsJournal of Neurosurgery, 1994
- A Correlative Study of p53 Protein Alteration and p53 Gene Mutation in Glioblastoma MultiformeBrain Pathology, 1993
- Subsets of Glioblastoma Multiforme Defined by Molecular Genetic AnalysisBrain Pathology, 1993
- Identification of Proliferating Cells in Human Gliomas Using the Monoclonal Antibody Ki-67Neurosurgery, 1988